11 related news articles for
-
Jessica’s story, ovarian cancer at a young age
Jessica Clark calls herself the luckiest unlucky person in the world – but she still wants to know why she got ovarian cancer at such a young age.… Read more
-
CUREator funds Hudson Institute biotech innovation
Exciting new treatments for unmet medical needs including ovarian cancer have been awarded significant funding from Australia’s national biotechnology incubator, CUREator.… Read more
-
Researchers frock up for Frocktober
For the month of ‘frocktober’ ovarian cancer researchers, Dr Maree Bilandzic and Dr Amy Wilson swapped their white lab coats for colourful frocks as part of the Frocktober campaign to raise funds and awareness for ovarian cancer research.… Read more
-
Ovarian cancer ‘invasion cells’ identified
Highly mobile, invasive ovarian cancer cells called ‘leader cells’ have been discovered as the cells that lead the attack on healthy tissue.… Read more
-
Funding to combat deadly ovarian cancer
Dr Bilandzic, an ovarian cancer researcher, has been awarded $700,000 for research into deadly ovarian cancer cells called ‘leader cells’, which can survive and even thrive in response to cancer treatment. … Read more
-
2019 IMPACT Philanthropy – Perpetual
Two Hudson Institute researchers, Dr Jun Yang and Dr Maree Bilandzic have been successful in the 2019 IMPACT Philanthropy program, from Perpetual, which are awarded to organisations based on their strategy, outcomes, capability and leaderships.… Read more
-
2019 Hudson Institute Travel Awards and Bryan Williams Trainee Scholarship
Congratulations to the 2019 Hudson Institute Travel Awards recipients who will attend international conferences and visit laboratories to build invaluable knowledge in their area of research.… Read more
-
Fighting ovarian cancer at the front line
Ovarian cancer is responsible for more deaths than any other gynaecological disease, yet it’s known as the ‘silent killer’, due to an absence of symptoms and a devastatingly low survival rate of less than 50 per cent. Our leading ovarian cancer researchers are progressing solutions to help these women – thanks to support from the… Read more
-
Ovarian Cancer Research Symposium
Ovarian cancer research leaders from across Australia met at Hudson Institute of Medical Research on Thursday, 15 November, for a new research symposium focused on progressing solutions to the disease.… Read more
-
Towards an early detection test for ovarian cancer
The Active Ratio Test represents an exciting step forward in innovative ovarian cancer research. Should it be successful, a test as simple as taking a swab or blood sample will result in the early detection of ovarian cancer in women who otherwise exhibit no symptoms. Vague and misleading symptoms, combined with the need for invasive… Read more
-
2018 Fielding Foundation Fellowship and Innovation Award announced
Hudson Institute’s brightest scientific minds and most promising discoveries will be progressed, thanks to support from a leading philanthropist, Mr Peter Fielding and the Fielding Foundation. The 2018 Fielding Innovation Award has been awarded to Dr Maree Bilandzic to develop more effective treatments for women with ovarian cancer. The 2018 Fielding Foundation Fellowship has been… Read more